Chapel Hill startup with ties to UNC lands rights to drug offering hope to cystic fibrosis patients
Posted Oct 27, 2019
Path BioAnalytics (PBA), a precision medicine startup with ties to UNC, has scored the rights to a new drug therapy offering hope to cystic fibrosis (CF) patients with rare mutations. PBA is a graduate of Launch Chapel Hill, an accelerator program based in Chapel Hill, as well as the Kenan Flagler Business School program Startup UNC.
(WRAL Tech Wire)
Related: Campus Connections
Carolina Insider Podcast: UNC Basketball Opener, Football Dominates FSU, Tom Jensen InterviewIt wasn't always easy, but the Tar Heels dispatched Elon, 90-76, Monday in the Smith Center (2:35). It WAS pretty easy for UNC Football as...
Tue Nov 5, 2024New UNC Team Store Moving In to Former ‘Library’ Space on Franklin Street
A new UNC team store is now open at the storefront on 120 East Franklin Street in downtown Chapel Hill with Dyehard by Follett, which...
Sun Oct 27, 2024
From Waffles to Tapas, a Popular Franklin Street Address Gets a New Look
The Chapel Hill community was saddened by the announcement of Ye Olde Waffle Shoppe’s closing in 2020, but the 173 East Franklin Street space now...
Sun Oct 27, 2024
Carolina Insider Podcast: UNC Football Visits UVa., Basketball Exhibition, "Concert for Carolina"
Jones Angell and Adam Lucas preview UNC Football's matchup with the Virginia Cavaliers (4:58). The Creative Director for Luke Combs, Zack Massey, joins to discuss...
Fri Oct 25, 2024